LifeVantage

LifeVantage Difference

  • LifeVantage is a NYSE listed company that is a pioneer in nutrigenomics, the study of how nutrition is activated at the cellular level. The market cap at year end 2024 exceeded $200 million.
  • Commenced operations in 1988, they have decades of research studies and customer activation around reducing oxidative stress.
  • LifeVantage Promise:
    • Safe and effective ingredients sourced from ethical suppliers globally.
    • Rigorous 22 point inspection of all raw materials, all finished products are quality reviewed and then also tested by an independent third party.
    • Deep commitment to sustainability of products and packaging.
  • LifeVantage is one of first to market with a patent pending GLP1 agonist alternative that is designed to activate the GLP-1 pathways and stimulate the body’s own natural production of the GLP-1 hormone.
Join our Provider Family